聯合電刺激與聲學放大之聽神經植入器
PMA 核准號：P130016 · 2026-04-30
廣告
決定日期2026-04-30
PMA 編號P130016
產品代碼PGQ
器械分類3 類
醫療專科U
諮詢委員會中文(台灣):
此醫療設備之規範性文件遵循「醫療規範-v1」政策。以下為該文件之翻譯：
此醫療設備已通過美國食品藥品管理局（FDA）的510(k)認證，並獲得PMA許可。該設備的臨床試驗編號為NCTXXXXXXX，並在PubMed上以PMIDXXXXXXX登錄。該設備的識別碼為XXXXXXXX，相關資訊請參考以下網址：[URL]。
公司名稱：[公司名稱]
產品名稱：[產品名稱]
器材摘要
Cochlear implant with combined electrical stimulation and acoustic amplification is the device name listed in this FDA 510(k) record. The listed applicant is Cochlear Americas. It received FDA 510(k) clearance on 2026-04-30. The device is classified under product code PGQ. It was reviewed by the EN advisory panel.
常見問題
What is the Cochlear implant with combined electrical stimulation and acoustic amplification?
Cochlear implant with combined electrical stimulation and acoustic amplification is a medical device that received FDA 510(k) clearance on 2026-04-30. The listed applicant is Cochlear Americas.
When did Cochlear implant with combined electrical stimulation and acoustic amplification receive FDA 510(k) clearance?
The clearance date for Cochlear implant with combined electrical stimulation and acoustic amplification can be found in the official FDA records.
Who is the listed applicant for Cochlear implant with combined electrical stimulation and acoustic amplification?
The FDA 510(k) record lists Cochlear Americas as the applicant. This does not by itself establish the device manufacturer.
What is the FDA product code for Cochlear implant with combined electrical stimulation and acoustic amplification?
The FDA product code for Cochlear implant with combined electrical stimulation and acoustic amplification is PGQ.
相關臨床試驗
相關紀錄係使用名稱、產品代碼或其他後設資料自動配對。配對結果並不構成已驗證的臨床、科學、企業或監管關係，請查閱連結的官方來源。
官方來源
在 FDA 資料庫中查看 →資料來源為 FDA Open API。如需最新且權威的資訊，請始終參閱官方記錄。
廣告